Special Issue:
Challenges and Opportunities in Pharmacology
Lisbeth Miranda-Mosqueda
Department of Pharmacology, Behavioral Pharmacology Laboratory, Faculty of Medicine, National Autonomous University of Mexico, Mexico City CDMX, C.P. 04510
Stacy Ruiz-Oropeza
Department of Pharmacology, Behavioral Pharmacology Laboratory, Faculty of Medicine, National Autonomous University of Mexico, Mexico City CDMX, C.P. 04510
Claudia Gomez-Acevedo
National Autonomous University of Mexico
Abstract
Ischemic cerebrovascular diseases are the leading cause of mortality and disability worldwide. Given the need for a pharmacological treatment for these diseases, agmatine has gained great interest due to its neuroprotective properties.
This article explores the properties of agmatine in ischemic events and their underlying mechanisms. Agmatine, considered as a neuromodulator, exerts its effects through its interaction with various molecular targets, including glutamate receptors, nitric oxide synthase, and metalloproteinases. Its ability to cross the blood-brain barrier and its role in neurotransmission processes postulate agmatine as a potential candidate for neuroprotection. Agmatine has a positive effect in the central nervous system to counteract excitotoxicity, oxidative stress, inflammation, alteration of the blood-brain barrier and energy disorders during ischemic events. This review describes the multiple interactions of agmatine within the ischemic cascade known to date, showing its ability to mitigate free radical formation, attenuate excitotoxicity, modulate inflammatory responses, stabilize the blood-brain barrier, and preserve mitochondrial function.
These properties position agmatine as a promising therapeutic agent for ischemic cerebrovascular diseases.
Luiz Henrique Alvarenga, MD
Postgraduate Program in Structural and Functional Interactions in Rehabilitation-University of Marília (UNIMAR) – Marília – SP, Brazil
Gabrielle Gomides Marconato, MD
Department of Biochemistry and Pharmacology, School of Medicine – UNIMAR
Gabriele Garcia Fracaro, MD
Department of Biochemistry and Pharmacology, School of Medicine – UNIMAR
Lucas Fornari Laurindo, MD
Department of Biochemistry and Pharmacology, School of Medicine – UNIMAR
Adriano Cressoni Araujo, Dr, PhD
Postgraduate Program in Structural and Functional Interactions in Rehabilitation-University of Marília (UNIMAR) – Marília – SP, Brazil ; Department of Biochemistry and Pharmacology, School of Medicine – UNIMAR
Claudio José Rubira, Dr, PhD
Hospital Beneficente UNIMAR – São Paulo, Brazil
Jefferson Aparecido Dias, Dr, PhD
Postgraduate Program in Structural and Functional Interactions in Rehabilitation-University of Marília (UNIMAR) – Marília – SP, Brazil; Postgraduate Program in Law – UNIMAR – Marília SP, Brazil
Sandra Maria Barbalho
Postgraduate Program in Structural and Functional Interactions in Rehabilitation-University of Marília (UNIMAR) – Marília – SP, Brazil; Department of Biochemistry and Pharmacology, School of Medicine – UNIMAR; School of Food and Technology of Marilia (FATEC) – São Paulo, Brazil.
Elen Landgraf Guiguer, Dr, PhD
Postgraduate Program in Structural and Functional Interactions in Rehabilitation-University of Marília (UNIMAR) – Marília – SP, Brazil; Department of Biochemistry and Pharmacology, School of Medicine – UNIMAR; School of Food and Technology of Marilia (FATEC) – São Paulo, Brazil.
Abstract
Osteoarthritis (OA) is a joint disorder characterized by chronic, degenerative, and irreversible inflammation leading to pain and disability. The standard drugs are ineffective for many patients and are usually associated with numerous side effects such as gastrointestinal complaints. Curcuma longa and its bioactive compounds have been considered for OA. The objective of this study was to perform a systematic review of the effects of Curcuma longa and its derivatives on OA. Pubmed, Cochrane, and Embase were searched, and PRISMA guidelines were followed to build this review. Only Randomized Clinical Trials (RCTs) that performed placebo-comparison were included. Most included studies showed that Curcuma longa or formulations prepared with curcuminoids can benefit the OA scores such as Visual Analog Scale, Knee injury and Osteoarthritis Outcome Score, Western Ontario and McMaster Universities Osteoarthritis Index; and Lequesne’s pain functional index. The use of Curcuma longa extracts or curcuminoids can benefit patients with OA. Nevertheless, the available RCTs show treatment time, doses, and formulations heterogeneity. Thus, the standardization of RCTs can guide researchers and physicians on the dosages and formulations that are most effective in addressing this condition, which is very prevalent in the world’s populations.
Shitang Ma
College of biological and pharmaceutical engineering, West Anhui University, Lu’an, China.
Jiafu Hou
Mudanjiang Medical University, Mudanjiang, China.
Shijuan Liu
Mudanjiang Medical University, Mudanjiang, China.
Fucheng Zhu
College of biological and pharmaceutical engineering, West Anhui University, Lu’an, China.
Peipei Wei
College of biological and pharmaceutical engineering, West Anhui University, Lu’an, China.
Chengtao Feng
Anhui University of Chinese Medicine, Hefei, China.
Naidong Chen
College of biological and pharmaceutical engineering, West Anhui University, Lu’an, China.
Abstract
The need for therapeutics to overcome development of existing diseases research to discover new lead agents. In the face of public health challenges worldwide, natural medicines play a pivotal role in innovative lead drug discovery. Network pharmacology can easily construct complicated poly-pharmacology network based on lead compound, biological function, and bioactive target proteins, which meets the overall feature of natural medicines, and enable to elucidate the action mechanism at molecule-protein level with systematic view. In this work, we first summarized the recent progress delineating lead drug development and its interaction with natural medicines. Second, we focused on the relationship between natural medicines and network pharmacology. Additionally, we discussed current issues and potential prospects for the lead drug discover from natural medicines by network pharmacology. Further investigations should be focus on relevant structural analysis for biological experiment, also the dynamic and quantitative network development. In summary, it is a rational approach for innovative lead drug discovery, and with the development of structure and biology research, this approach makes it a very powerful method for the lead molecules in a high-throughput manner from a comprehensive and powerful special multi-compound to target protein/disease poly pharmacology network.
Georg Ferber, PhD
Statistik Georg Ferber GmbH, Riehen, Switzerland
Dilshat Djumanov, PhD
Richmond Pharmacology Limited, London, UK
Ulrike Lorch, MD, FFPM
Richmond Pharmacology Limited, London, UK
Edward Jackson, BSc, MSc, PhD, MBChB
Richmond Pharmacology Limited, London, UK
Joao Almeida Melo, MD
Richmond Pharmacology Limited, London, UK
James Rickard, MPharm
King’s College London, UK, Richmond Research Institute – St George’s University of London, UK
Jorg Taubel, MD, FFPM, FESC
Richmond Pharmacology Limited, London, UK; St George’s University of London, UK, Statistik Georg Ferber GmbH, Riehen, Switzerland; King’s College London, UK; Richmond Research Institute – St George’s University of London, UK
Abstract
The electrical activity of the heart, characterised by the QT interval on an electrocardiogram (ECG), serves as a crucial parameter for evaluating cardiac health. Variations in the QT interval, particularly when corrected for heart rate using Fridericia’s formula (QTcF), have long been of interest in cardiology and play a pivotal role in assessing cardiac safety in clinical trials. Understanding the influence of meals given at different times on QTcF intervals is essential for the accurate execution of Thorough QT (TQT) studies. Moreover, it has been proposed that this meal-related QT interval shortening could serve as a valuable indicator of assay sensitivity in TQT studies or even as a potential integration of TQT investigations into in Phase I/II studies.
This study explores the impact of meals on QTcF intervals, specifically in the context of pharmacodynamic studies and TQT investigations. The primary goal is to gain insights into how different meals and baseline calculations affect QTcF changes and their potential implications for cardiac health and the risk of arrhythmias. Recent research has begun shedding light on the intricate relationship between meal composition, timing, and QTcF alterations. Several studies have investigated the effects of various nutrients, such as carbohydrates, fats, and proteins, on QTcF duration, as well as the implications of postprandial changes. These investigations have unveiled the complex interplay between dietary components and the cardiovascular system, raising essential questions about how our dietary choices may influence cardiac electrophysiology.
In this comprehensive meta-analysis, we analyse data from nine studies, all conducted in accordance with Good Clinical Practice and ethical standards. These studies were approved by Ethics Committees and Regulatory authorities. Our analysis focuses on ECG assessments, involving the use of 12-lead ECGs recorded electronically and evaluated by certified cardiologists. We apply the Fridericia formula for QT correction (QTcF), as it has been shown to provide more accurate results across different heart rates compared to other correction methods.
Our findings confirm existing literature into the impact of meals on QTcF intervals. We observe a consistent shortening of QTcF following breakfast, exceeding 5 milliseconds, which aligns with the positive control requirement defined by ICH E14, thus demonstrating the validity of our approach. In contrast, the effect of lunch is consistently less than 5 milliseconds across various timepoints and studies, indicating differences in the meal-related QTcF changes.
Furthermore, our analysis incorporates gender-based assessments, showing that women exhibit a smaller effect than men, which is significant for breakfast and the fasted condition. These results suggest that the observed QTcF effect post-breakfast is a combination of the meal itself and factors unique to the initial day of a study. This insight holds potential for improving the design and interpretation of cardiac safety studies, particularly in Phase I investigations, and may offer the opportunity to explore the removal of positive control agents like Moxifloxacin, thereby reducing exposure to harmful challenge agents and contributing to the global effort to combat antimicrobial resistance (AMR).
In conclusion, this meta-analysis advances our understanding of meal-induced QTcF changes and their significance in cardiac safety assessment, offering the prospect of more efficient and patient-focused drug development practices. This not only contributes to enhanced safety but also supports the reduction of antibiotic consumption, a key element in the global fight against AMR.
Sandra Maria Barbalho
Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzi Filho, 1001, 17.525–902, Marília, São Paulo, Brazil; Postgraduate Program in Structural and Functional Interactions in Rehabilitation – (UNIMAR), Avenida Hygino Muzzi Filho, 1001, 17.525–902, Marília, SP, Brazil
Katia P Sloan
Texas Institute for Kidney and Endocrine Disorders, Lufkin, Texas, USA. 10 Medical Center Blvd, STE A – Lufkin TX 75904 – USA
Lance A Sloan
Texas Institute for Kidney and Endocrine Disorders, Lufkin, Texas, USA. 10 Medical Center Blvd, STE A – Lufkin TX 75904 – USA; University of Texas Medical Branch, Department of Internal Medicine, Galveston, Texas, USA. 301 University Blvd, Galveston TX 77555 – USA
Ricardo A Goulart
Postgraduate Program in Structural and Functional Interactions in Rehabilitation – (UNIMAR), Avenida Hygino Muzzi Filho, 1001, 17.525–902, Marília, SP, Brazil
Karina R. Quesada
Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzi Filho, 1001, 17.525–902, Marília, São Paulo, Brazil
Lucas Fornari Laurindo
Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzi Filho, 1001, 17.525–902, Marília, São Paulo, Brazil
Tereza Lais Menegucci Zutin
Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzi Filho, 1001, 17.525–902, Marília, São Paulo, Brazil
Marcelo Dib Bechara
Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzi Filho, 1001, 17.525–902, Marília, São Paulo, Brazil; Postgraduate Program in Structural and Functional Interactions in Rehabilitation – (UNIMAR), Avenida Hygino Muzzi Filho, 1001, 17.525–902, Marília, SP, Brazil
Abstract
Despite the possible effects of Vitamin D (VD) in decreasing the risk of infections and mortality in some viral diseases, the role of therapeutic VD supplementation in individuals infected with COVID is still obscure. This article reviews the possible effects of VD on COVID-19 severity. MEDLINE–PubMed, EMBASE, and Cochran were searched following PRISMA guidelines. Some studies have reported that VD does not seem to augment the immunogenicity of seasonal vaccines, nor does it significantly reduce the incidence or duration of upper respiratory tract infection, although others have. The reason for not getting a positive or significant difference may be due to inadequate VD treatment levels, and VD may not be that important in immunized individuals with adaptive immunity. VD deficiency is most prevalent in the elderly, obese, men, ethnic minorities with darker skin, people with diabetes, hypertension, and in nursing homes or institutionalized. These are individuals that are at increased risk of severe consequences of COVID-19 such as acute respiratory distress syndrome with the need for mechanical ventilation and death. Perhaps supplementation of VD to adequate VD levels will improve the inflammatory reaction and modulate a faster patient recovery with decreased morbidity and mortality.
Yunfeng Zhao
Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center in Shreveport, Shreveport, LA 71130, USA
Annapoorna Sreedhar
Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center in Shreveport, Shreveport, LA 71130, USA
Chunjing Zhang
Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center in Shreveport, Shreveport, LA 71130, USA; School of Basic Medicine, Qiqihar Medical University, Qiqihar, Heilongjiang 161006, China
Noel Jacquet
Department of Pharmacology, Toxicology & Neuroscience, LSU Health Sciences Center in Shreveport, Shreveport, LA 71130, USA
Abstract
Upregulation of uncoupling protein 2 (UCP2) is considered a prosurvival mechanism for cancer cells. This prosurvival function is thought to be mediated by UCP2’s uncoupling activity which reduces the production of superoxide in the mitochondria. However, exactly how highly expressed UCP2 regulates cell proliferation, cell cycle, and cell death during the early stage of tumorigenesis has not been studied thoroughly. For this purpose, we generated UCP2 stably overexpressed JB6 Cl-41 cells (a skin cell transformation model) and performed studies to answer the above questions. Our results demonstrated that UCP2 overexpression enhanced cell proliferation, activation of the oncoprotein Fra-1, anchorage-independent growth, 3D spheroids growth, and glucose uptake during skin cell transformation. Next, our results demonstrated that UCP2 overexpression resulted in marked decreases in the proportion of the cells in the G1 phase and an increase of cells in the S phase of the cell cycle, which was accompanied by increased expression of Cyclin E and Cdk2. Lastly, UCP2 overexpression did not enhance or suppress apoptosis during skin cell transformation, as indicated by Annexin V and active caspase 3/7 staining. Taken together, these data suggest that UCP2 upregulation mainly enhances the Fra-1 oncogenic pathway which drives cell proliferation, without inhibiting apoptosis during skin cell transformation.
Shikha Jaiswal, M.D.
Pharmacology, Pt. JNM Medical College Raipur C.G., Pt. JNM Medical College Raipur C.G., Raipur-492001, India
Ajay Kumar Halwai, M.D.
Pharmacology, Pt. JNM Medical College Raipur C.G., Pt. JNM Medical College Raipur C.G., Raipur-492001, India
Ajitesh Kumar Mishra
Pharmacology, Pt. JNM Medical College Raipur C.G., Pt. JNM Medical College Raipur C.G., Raipur-492001, India
Divish Aggarwal
Pharmacology, Pt. JNM Medical College Raipur C.G., Pt. JNM Medical College Raipur C.G., Raipur-492001, India
Raka Sheohare, M.D. FNIC
Medicine, Madhumeet Hospital, Avanti Vihar, Raipur-492001, India
Abstract
Background: Healthcare workers are at a higher risk of having Covid infection than other professionals. Thus, it is more important for them to wear face masks for themselves and for the sake of their co-workers and public health. The use of face masks is mainly limited by their perceived discomfort and concerns regarding inadequate gas exchange. Still, there are serious concerns about the use of masks over a long period.
Aims: This study aimed to study the effects of different types of face masks on clinical parameters like oxygen saturation, Respiratory rate, and pulse rate.
Methods: A cross-sectional observational study was conducted on 218 subjects from March 2021 to April 2021. They used different types of masks-like cloth masks, surgical masks, N95 masks, and double masks. A pulse oximeter applied to the index finger was used for the non-invasive determination of clinical parameters like oxygen saturation, heart rate, and respiratory rate.
Results: There was a significant decrease in oxygen saturation seen in subjects using the surgical mask and N-95 mask, but there was no change in oxygen saturation in participants who wore cloth masks. In our study, heart rates increased significantly at the end of the study in all groups irrespective of the mask they wore. However, the respiratory rate increased significantly only in those participants who wore N-95 masks.
Conclusion: Our study concludes that wearing a face mask for a long period induces an increase in heart rate and shortness of breath along with a significant reduction in oxygen saturation.
Marina Lancaster D. de Moraes Salles
Department of Biochemistry and Nutrition, School of Nutrition, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Nataly Garcia
Department of Biochemistry and Nutrition, School of Nutrition, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Lucas Fornari Laurindo
Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Angiseli Damaceno Scanavacca
Department of Biochemistry and Nutrition, School of Nutrition, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Karla Regina Ezídio
Department of Biochemistry and Nutrition, School of Nutrition, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Ricardo José Tofano
Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Cláudia Rucco Penteado Detregiachi
Department of Biochemistry and Nutrition, School of Nutrition, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil; Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Jesselina F. dos Santos Haber
Department of Biochemistry and Nutrition, School of Nutrition, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Mara Silva Foratto Marconatto
Department of Biochemistry and Nutrition, School of Nutrition, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Sandra Maria Barbalho
Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil; Postgraduate Program in Structural and Functional Interactions in Rehabilitation, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil; Department of Biochemistry, School of Food and Technology of Marilia (FATEC), Avenida Castro Alves, 62, Marília, São Paulo 17500-000, Brazil
Karina Quesada
Department of Biochemistry and Nutrition, School of Nutrition, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil; Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Hygino Muzzy Filho, 1001, Marília, São Paulo 17525-902, Brazil
Abstract
Poor sleep quality can affect cardiovascular health and is considered a significant risk factor for the development of risk factors for Metabolic syndrome (MetS). This study aimed to investigate possible associations between sleep quality measured by the Pittsburgh Sleep Quality Index and the MetS. This was a cross-sectional that comprised data from 208 patients. Biochemical and anthropometric parameters were assessed. The identification of MetS was performed according to the International Diabetes Federation guidelines. The quantitative variables were described with the support of the BioEstat 5.3 software. To assess the association of the studied variables with the diagnosis of MetS, the Mann-Whitney and Chi-square (n x n) statistical tests were used. The level of significance considered was 5%. According to the International Diabetes Federation criteria, 111 (53,36%) men and women presented MetS. There were no statically significant differences between the groups with or without sleep disorders and the values of waist circumference (p=0.6996), high-density lipoprotein cholesterol levels (p=0.7940), triglycerides levels (p=0.8703), blood pressure values (p= 0.9851, and p=0.9795 for systolic and diastolic blood pressure, respectively), and glycemia (p=0.5351). Eighty-eight volunteers (42%) presented sleep quality dysfunction, with the highest proportion observed among individuals affected by MetS (p=0.0019). Our results indicate an association between sleep quality and the prevalence of MetS . Therefore, sleep quality could be evaluated in patients with MetS so that the therapeutic strategy would not be limited to the intervention in biochemical and anthropometric factors.
David J. Tittle
ElleVet Sciences, Product Development and Scientific Comnmunications, South Portland, ME 04106
Joseph J Wakshlag
Department of Clinical Sciences, Cornell College of Veterinary Medicine, Ithaca, NY 14853
Wayne S Schwark
Department of Molecular Medicine, Cornell College of Veterinary Medicine, Ithaca, NY, 14853
Alex Lyubimov
University of Illinois at Chicago, Department of Pharmacology, Chicago IL, 60612
Alexander Zakharov
University of Illinois at Chicago, Department of Pharmacology, Chicago IL, 60612
Beatriz Gomez
University of Illinois at Chicago, Department of Pharmacology, Chicago IL, 60612
Abstract
The aim of this study was to compare the pharmacokinetics of a cannabidiol (CBD) and cannabidiolic acid-rich (CBDA) hemp extract in a sesame oil base and a soft gel capsule formulation. During acute twenty-four hour pharmacokinetic evaluation, maximum serum concentration (Cmax) was higher for all measurable components in the serum (CBD, CBDA, Δ-9-tetrahydrocannabinol [THC] and tetrahydrocannabinolic acid [THCA]) following soft gel administration versus the oil formulation. Similar times of maximal serum concentration (Tmax) were observed with both presentations. Based on the area under the curve, a significant increase in CBDA absorption was observed following soft gel dosing. Whilst comparable, the steady state pharmacokinetic data after one week of twice daily dosing shows an increased concentration of CBDA, with a slightly lower CBD concentration with soft gel administration compared to oil. Although THC and THCA concentrations remain comparably low from both presentations, THCA absorption was superior regardless of formulation. When examining acceptance, soft gels are associated with increased palatability and less rejection of oral dosing with oil. Dogs, and potentially even people, may show increasing tolerance to this soft gel formulation; as such consideration should be given to the ease of administration and superior CBDA absorption with the use of a soft gel formulation of a CBD/CBDA hemp blend.
Yukie M. Lloyd
Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Hawaii, USA
Naveen Bobbili
Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Hawaii, USA
Ali Salanti
Centre for Medical Parasitology, Department of Immunology and Microbiology, University of Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Denmark
Philomina Gwanmesia
Faculty of Medicine and Biomedical Sciences, Biotechnology Centre, University of Yaoundé I, Yaoundé, Cameroon
Josephine Fogako
Faculty of Medicine and Biomedical Sciences, Biotechnology Centre, University of Yaoundé I, Yaoundé, Cameroon
Rose F.G Leke
Faculty of Medicine and Biomedical Sciences, Biotechnology Centre, University of Yaoundé I, Yaoundé, Cameroon
Diane W Taylor
Department of Tropical Medicine, Medical Microbiology and Pharmacology, John A. Burns School of Medicine, University of Hawaii at Manoa, Hawaii, USA
Abstract
Background: Women produce antibodies to VAR2CSA when infected with Plasmodium falciparum during pregnancy that reduce disease severity in the current and subsequent pregnancies. In addition to antibody quantity, antibody quality (e.g., avidity) and function (e.g., inhibition of binding and opsonic phagocytosis) are immunologically important. Studies comparing the quantity, avidity and effector mechanisms of antibodies to VAR2CSA in the same group of women with pregnancy outcomes, especially in low transmission areas, are limited.
Aims: The purpose of this study was to characterize antibodies to VAR2CSA using four assays, determine the correlation among the assays, and relate this to pregnancy outcome.
Methods: A panel of 310 plasma samples from women in Yaoundé (a city with low malaria transmission) who had antibodies to full-length VAR2CSA were screened in assays that measured i) level of antibodies to VAR2CSA, ii) antibody avidity, iii) reduction in binding (RiB) of fluorescent VAR2CSA-coupled beads to fluorescent-CSA-coupled beads, and iv) opsonic phagocytosis using VAR2CSA-coupled beads and human THP1 cells. Results from the assays were compared with clinical information from 614 women who were Ab-negative.
Results: A modest association was found among the 4 assays, i.e., as the amount of antibodies increased, a small increase in avidity, RiB and phagocytosis was observed; however, the association between RiB and avidity was poor. When results were dichotomized to above and below the median, antibody avidity, but not antibodies in the other assays, was associated with a significant reduction in prevalence of placental malaria and lower placental parasitemia. However, women who had antibody values above the median in amount (p=0.03), avidity (p=0.006), reduction in binding (p=0.018) and probably phagocytosis (p=0.065) had significantly lower placental parasitemia than women who lacked Abs to VAR2CSA.
Conclusions: In this urban setting, women with the highest (above the median) antibody levels, in the four assays had a lower prevalence of placental malaria and placental parasitemia than women who lacked anti-VAR2CSA antibodies. Thus, VAR2CA-based vaccine trials in low transmission areas should consider using all four assays before and after vaccination.
Aleksandr L. Urakov
Department of General and Clinical Pharmacology, Izhevsk State Medical Academy, Kommunarov str., 281, 426034, Izhevsk, Russia
Yulia A. Sorokina
Department of General Pharmacology, Volga Medical Research University, pl. 10/1 Minin and Pozharsky str., 603005, Nizhny Novgorod, Russia
Lubov V. Lovtsova
Department of General Pharmacology, Volga Medical Research University, pl. 10/1 Minin and Pozharsky str., 603005, Nizhny Novgorod, Russia
Abstract
Coronavirus infection influences on multiple organs and contributes to the progression of concurrent diseases. The most notable and outstanding changes and COVID complications appear in patients with pre – existing cardiovascular and metabolic disturbances especially in elderly. There is evidence that acute viral as well as chronical diseases promote rapid cell senescence and prolong the process of recovery from disease. This review reflects the main common points and axis joining the pre-existing diseases and coronavirus infections complications and resolution. Diabetes mellitus type 2 and cardiovascular diseases (hypertension) predispose to severe outcome of the disease and the COVID-19 mortality risk. The Klotho protein level may be promising predictor of COVID severity and complications in many patients. In order to control properly the rehabilitation process and estimate the level of treatment efficacy we tried to reflect the property of milestone clue biomarker of senescence and cell damage – Klotho protein.
Larry L Mweetwa
Department of Pharmacy, Boitekanelo College, Plot 5824 Masetlheng Rd, Gaborone 00000, Botswana
Tiro Mampane
Department of Pharmacy, Boitekanelo College, Plot 5824 Masetlheng Rd, Gaborone 00000, Botswana
Thatoyaone J Kenaope
Department of Pharmacy, Boitekanelo College, Plot 5824 Masetlheng Rd, Gaborone 00000, Botswana
Bonang Mosala
Department of Pharmacy, Boitekanelo College, Plot 5824 Masetlheng Rd, Gaborone 00000, Botswana
Kenneth Pule
Department of Pharmacy, Boitekanelo College, Plot 5824 Masetlheng Rd, Gaborone 00000, Botswana
Gerald Juma Obure
Department of Pharmacy, Boitekanelo College, Plot 5824 Masetlheng Rd, Gaborone 00000, Botswana
Getrude Mothibe
Department of Pharmacy, Boitekanelo College, Plot 5824 Masetlheng Rd, Gaborone 00000, Botswana
Abstract
Nanobiotechnology is a multi-strategic approach that engineers biological components (atoms and molecules) at the nanoscales. The concept was introduced as an effective alternative with drug delivery and targeting properties. Nanobiotechnology has several applications in cancerous disease, autoimmune, inflammation, infectious, and viral diseases, and for the management of COVID-19. Nanoparticles have biomimetic properties, encapsulation, and safety formulation of drugs, and all these properties give them an advantage over conventional drug strategies. Nanobiotechnology research is currently progressive and needs extensive exploration and understanding for its potential use in future innovations. The present review studied the concept of nanobiotechnology, its origin, mechanism of drug delivery and targeting, applications, and future perspective in pharmacology and innovation to decipher its role in future advanced research.